Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.46 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.46 |
| ▸ | CD69 | Q07108 | 1/20 | 0.46 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.45 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17849187 | 0.91 | LGALS3 (0.55) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL20175842 | 0.89 | LGALS3 (0.52) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL15274901 | 0.89 | LGALS3 (0.45) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL16659352 | 0.89 | LGALS3 (0.45) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL18589697 | 0.89 | LGALS3 (0.45) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL20122239 | 0.86 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL20121276 | 0.86 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL15333778 | 0.86 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL17849186 | 0.84 | LGALS3 (0.54) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B | |
| SCHEMBL24844372 | 0.83 | BDNF (0.50) | LGALS3LGALS8LGALS4CD69LGALS7; LGALS7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150306237-A1 | HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES | UNIVERSITY OF GENEVA (CH) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306237-A1 | HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES | CD44, HAO2, LPO | LGALS3 206/4885LGALS8 495/4885LGALS4 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.